These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26513998)

  • 1. [The effect research of specific immunotherapy of allergic rhinitis and allergic rhinitis combined bronchial asthma].
    Deng B; Zhao Y; You Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 29(12):1090-3. PubMed ID: 26513998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of two commercial house dust mite extracts for allergic rhinitis: a head-to-head study.
    Li J; Wu Y; Yang Y; Huang N; Li W; Zhang S; Jiang Q; Yang L; Zhu R
    Int Forum Allergy Rhinol; 2019 Aug; 9(8):876-882. PubMed ID: 31322838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.
    Martín-Muñoz MF; Pineda F; Muiños T; Fontan M; Nevot S; Bosque M; Jurado Palomo J; Torredemer A; Valdesoiro L; Martinez Cañavate AM; Pedemonte Marco C;
    Allergol Immunopathol (Madr); 2013; 41(1):4-10. PubMed ID: 22321665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant improvement in symptoms, skin test, and specific bronchial reactivity after 6 months of treatment with a depigmented, polymerized extract of Dermatophagoides pteronyssinus and D. farinae.
    Ferrer A; García-Sellés J
    J Investig Allergol Clin Immunol; 2003; 13(4):244-51. PubMed ID: 14989113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy and safety of rush immunotherapy in patients with allergic rhinitis].
    Xie W; Zhang H; Chen J; Wang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):641-5. PubMed ID: 26696201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
    Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
    Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and economic evaluation of sublingual immunotherapy with Dermatophagoides farinae drops in patients with allergic rhinitis and allergic asthma].
    Wang MS; Wu HT; Huang XB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):538-542. PubMed ID: 29871064
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relationship between Dermatophagoides pteronyssinus and Dermatophagoides farinae sIgE in serum and local secretion of perennial allergic rhinitis patients].
    Chen J; Xiang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 17(2):71-3. PubMed ID: 12833684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Differences in Serum Quantitative Specific IgE Levels Induced by Dermatophagoides pteronyssinus, Dermatophagoides farinae and Blomia tropicalis Sensitization in Intermittent and Persistent Allergic Asthma.
    Susanto AJ; Rengganis I; Rumende CM; Harimurti K
    Acta Med Indones; 2017 Oct; 49(4):299-306. PubMed ID: 29348379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors.
    Lee JH; Kim SC; Choi H; Jung CG; Ban GY; Shin YS; Nahm DH; Park HS; Ye YM
    J Korean Med Sci; 2017 Jul; 32(7):1124-1130. PubMed ID: 28581269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of sublingual immunotherapy with Dermatophagoides Farinae on the expression of specific IgG4 in patients with allergic rhinitis in Hainan area].
    Huang Q; Wei X; Lin X; Zheng J; Huang H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 34(2):135-139. PubMed ID: 32086918
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of Sublingual Administration of Dermatophagoides Farinae Drops for Treatment of Pediatric Allergic Rhinitis Accompanied by Adenoid Hypertrophy and Improvement of Immune Function.
    Yu W; Mao L; Pan Q; He T; Yu M
    Med Sci Monit; 2019 Jan; 25():333-340. PubMed ID: 30633736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy and safety of subcutaneous immuno-therapy with dermatophagoides pteronyssinus for allergic rhinitis].
    Liu J; Wan J; Zhou Y; Liu Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 26(11):510-2. PubMed ID: 22934340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II/III clinical trial to assess the tolerability and immunological effect of a new updosing phase of Dermatophagoides mix-based immunotherapy.
    Tabar AI; González Delgado P; Sánchez Hernández C; Basagaña Torrento M; Moreno Benítez F; Arina M
    J Investig Allergol Clin Immunol; 2015; 25(1):40-6. PubMed ID: 25898693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term efficacy of Dermatophagoides pteronyssinus immunotherapy in patients with allergic rhinitis: a 3-year prospective study].
    Wang CS; Wang XD; Zhang W; She WY; Xi L; Ouyang YH; Zhao Y; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):804-8. PubMed ID: 23302159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short-term efficacy and factors of specific immunotherapy on patients with allergic rhinitis].
    Geng C; Yuan X; Xing Z; Yu L; Wang M; Lin Y; Liu Y; Zhang G
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Nov; 29(21):1857-9, 1863. PubMed ID: 26930905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A DNA vaccine encoding a chimeric allergen derived from major group 1 allergens of dust mite can be used for specific immunotherapy.
    Sun T; Yin K; Wu LY; Jin WJ; Li Y; Sheng B; Jiang YX
    Int J Clin Exp Pathol; 2014; 7(9):5473-83. PubMed ID: 25337189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.